FANCD2 and acute kidney injury: Finally, rescue of FANCD2 via treatment of kidney organoids exposed to repeated cisplatin doses with the DNA ligase IV inhibitor, SCR7 resulted in limited transition from intrinsic to incomplete repair, suggesting targeting of FANCD2/RAD51 pathway for halting disease progression in the AKI-CKD transition [29].